PR

Praram 9 Hospital Public Company Limited

PR9 · BK · Healthcare / Medical Care Facilities

18.80THB+0.20 (+1.08%)

Price History

Full chart

Market Stats

Previous Close18.60
Open18.60
Day Range18.40 – 19.10
52-Week Range15.25 – 23.27
Volume2.20M
Market Cap14.86B
P/E (TTM)18.35
Forward P/E15.60
EPS1.03
Dividend Yield2.65%
Beta0.13
50-Day Avg18.75
200-Day Avg17.79

About

Praram 9 Hospital Public Company Limited engages in hospital operations primarily in Thailand. The company operates medicine, surgery, diabetes and metabolic, spine, orthopedic, physical therapy and rehabilitation, chest and respiratory, neurology, thyroid and thyroid surgery, obstetrics gynecology, IVF, breast, oncocare, emergency, imaging, Lasik, skin and plastic surgery, mind, gastrointestinal and liver disease, dental, check-up, eye, pediatric, sleep, ear, nose, and throat centers, as well as vaccination and travel medicine, and traditional Chinese medicine clinics. It also engages in the operation of kidney disease and transplantation, cardiovascular, and pain management and wellness institutes. Praram 9 Hospital Public Company Limited was founded in 1992 and is based in Bangkok, Thailand.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Satian Pooprasert M.D.
  • Employees0
  • Headquarters99, Rama IX Road, Bangkok, Thailand, 10310, Thailand
  • Websitehttps://www.praram9.com

Leadership

  • Dr. Satian Pooprasert M.D.Vice Chairman, MD & CEO · b. 1953
  • Ms. Kamaporn TumpipitCFO, Head of investor relations and Deputy MD of Accounting & Finance Department
  • Prof. Korpong RookkapanDeputy Managing Director of Quality and Operations
  • Ms. Duangkamol WongsaitaChief Accountant
  • Ms. Marisara ThanasaksiriCompany Secretary & Head of Compliance · b. 1970
  • Ms. Sasivimon SuksaiChief of Internal Audit · b. 1967
  • Dr. Wittaya WanpenDeputy Managing Director of Business Development & Strategy Office
  • Dr. North TechawathanawannaDeputy Managing Director of Medical & Human Resources

Financials

Income Statement

Currency: THB2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.78B1.96B2.24B2.42B2.70B2.85B2.60B2.99B4.11B4.20B4.64B5.28B
Growth (%)-+10.31%+14.19%+8.18%+11.55%+5.46%-8.68%+14.82%+37.52%+2.30%+10.31%+13.83%
Cost of Revenue1.18B1.26B1.53B1.68B1.86B1.97B1.89B2.17B2.72B2.82B3.05B3.39B
Gross Profit592.78M699.86M705.44M739.86M836.88M876.20M711.53M814.56M1.38B1.38B1.59B1.89B
Gross Margin33.36%35.70%31.52%30.55%30.98%30.76%27.35%27.27%33.69%32.89%34.30%35.73%
Operating Expense389.43M451.84M387.92M422.77M621.16M550.34M486.73M518.03M691.97M722.84M782.06M987.69M
Operating Income203.35M248.03M317.52M317.09M215.72M325.86M224.80M296.53M691.81M659.09M807.89M897.81M
Operating Margin11.44%12.65%14.19%13.09%7.99%11.44%8.64%9.93%16.84%15.69%17.43%17.02%
EBITDA310.71M361.92M449.35M454.05M371.54M482.07M437.78M590.25M991.29M941.45M1.17B1.21B
EBITDA Margin17.48%18.46%20.07%18.75%13.76%16.92%16.83%19.76%24.13%22.40%25.22%22.95%
Net Income162.16M193.59M259.81M262.26M157.23M284.46M202.05M249.17M567.61M557.86M712.68M822.71M
Net Income Margin9.13%9.88%11.61%10.83%5.82%9.99%7.77%8.34%13.82%13.28%15.37%15.59%
Interest Expense---000470.00K479.29K479.87K636.85K491.74K764.08K
Interest Expense % of Total Revenue---0.00%0.00%0.00%0.02%0.02%0.01%0.02%0.01%0.01%

Balance Sheet

Currency: THB2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.82B2.05B2.29B2.86B4.42B4.72B4.80B5.14B5.56B5.91B6.40B7.03B
Total Liabilities261.81M379.52M412.99M761.56M551.04M677.64M681.81M859.06M822.39M830.35M960.56M1.15B
Total Equity1.56B1.67B1.88B2.10B3.87B4.04B4.12B4.28B4.74B5.08B5.44B5.88B
Cash325.19M178.94M208.74M237.80M223.50M631.77M592.47M690.38M1.57B1.75B394.82M660.51M
Total Debt------7.83M6.18M7.69M8.88M4.80M15.98M
Net Debt-325.19M-178.94M-208.74M-237.80M-223.50M-631.77M-584.64M-684.20M-1.56B-1.74B-390.03M-644.52M

Cash Flow

Currency: THB2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--388.04M442.26M479.58M490.04M423.77M588.02M892.54M804.07M1.04B1.05B
Investing Cash Flow---311.01M-366.05M-1.99B29.79M-348.84M-398.86M97.37M-377.94M-2.04B-422.28M
Financing Cash Flow---47.23M-47.14M1.49B-111.55M-114.23M-91.26M-115.23M-240.28M-357.74M-359.01M
Capital Expenditure00331.44M540.33M816.16M838.61M750.59M252.70M162.99M307.07M249.24M492.79M
Free Cash Flow--56.60M-98.07M-336.58M-348.57M-326.82M335.32M729.55M497.00M790.64M554.18M
Dividends Paid--47.23M47.14M491.51M111.55M110.21M86.17M109.74M234.33M351.25M351.44M
FCF to OCF--14.59%-22.18%-70.18%-71.13%-77.12%57.02%81.74%61.81%76.03%52.93%
Dividend Paid to FCF--83.44%-48.07%-146.03%-32.00%-33.72%25.70%15.04%47.15%44.43%63.42%

Earnings

Report DateNov 28, 2018Feb 22, 2019May 14, 2019Aug 13, 2019Nov 12, 2019Feb 18, 2020May 14, 2020Aug 11, 2020Nov 12, 2020Feb 16, 2021May 13, 2021Aug 10, 2021Nov 11, 2021Feb 16, 2022May 12, 2022Aug 11, 2022Nov 10, 2022Feb 22, 2023May 15, 2023Aug 10, 2023Nov 9, 2023Feb 19, 2024May 14, 2024Aug 7, 2024Nov 10, 2024Feb 18, 2025May 15, 2025Aug 14, 2025Nov 7, 2025Feb 17, 2026May 12, 2026Aug 11, 2026
EPS Estimate-0.110.080.090.100.10-0.010.060.090.060.030.110.120.140.150.170.180.160.150.180.200.190.240.230.270.240.260.290.280.250.24
EPS Actual0.150.100.110.050.120.090.050.010.090.110.050.010.110.150.200.160.190.170.140.150.180.240.200.180.260.270.250.230.280.280.230.23
Surprise--9.09%37.50%-44.44%20.00%-10.00%-0.00%50.00%22.22%-16.67%-66.67%0.00%25.00%42.86%6.67%11.76%-5.56%-12.50%0.00%0.00%20.00%5.26%-25.00%13.04%0.00%4.17%-11.54%-3.45%0.00%-8.00%-4.17%
Timing-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap14.86B
Enterprise Value12.62B
Trailing P/E18.35
Forward P/E15.60
PEG Ratio1.81
Price / Sales2.74
Price / Book2.55
EPS1.03
Book Value7.64
Revenue (TTM)5.43B
Gross Profit (TTM)2.00B
EBITDA1.27B
Profit Margin14.91%
Operating Margin16.59%
Return on Equity13.91%
Return on Assets8.60%
Shares Outstanding786.30M
Shares Float456.41M
Beta0.13
Dividend Yield2.65%
Dividend Rate0.50
Payout Ratio68.63%

Dividends

20262×
0.20Aug 24, 20260.30Apr 30, 2026
20252×
0.20Nov 20, 20250.25May 7, 2025
20242×
0.15Nov 22, 20240.30May 2, 2024
20231×
0.29May 2, 2023
20221×
0.14May 5, 2022
20211×
0.11Apr 30, 2021
20201×
0.14Apr 20, 2020
20191×
0.14May 7, 2019